OKYO Pharma News

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 9 13:24 ET

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 4 06:35 ET

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 2 07:04 ET

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 29 14:32 ET

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 22 07:01 ET

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 21 07:06 ET

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 20 08:12 ET

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Feb 9 07:04 ET

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jan 31 07:01 ET

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jan 8 00:00 ET

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jan 5 00:00 ET

OKYO Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

Dec 21, 2023 07:35 ET

OKYO Pharma | 424B5: Prospectus

Dec 20, 2023 17:30 ET

OKYO Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

Dec 18, 2023 16:56 ET

OKYO Pharma | 424B5: Prospectus

Dec 15, 2023 17:46 ET

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 4, 2023 07:00 ET

OKYO Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Nov 29, 2023 07:00 ET

OKYO Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 1, 2023 16:55 ET

OKYO Pharma | 424B5: Prospectus

Oct 31, 2023 16:59 ET

OKYO Pharma | 4: Statement of changes in beneficial ownership of securities-Executive Chairman CERRONE GABRIELE M

Oct 31, 2023 16:15 ET